Suppr超能文献

大麻使用者主动脉瘤和夹层开放修复术后的结果。

Outcomes after open repair of aortic aneurysms and dissections in cannabis consumers.

作者信息

Bernal Lucas Ribé, Tanaka Akiko, Ikeno Yuki, Afifi Rana O, Sandhu Harleen K, Miller Charles C, Estrera Anthony L

机构信息

Department of Cardiothoracic and Vascular Surgery, McGovern Medical School at UTHealth Houston, Houston, Tex.

出版信息

JTCVS Open. 2024 Aug 19;22:107-113. doi: 10.1016/j.xjon.2024.08.002. eCollection 2024 Dec.

Abstract

OBJECTIVE

To investigate the influence of cannabis consumption on the mid- and long-term surgical outcomes of patients with aortic aneurysms or dissections.

METHODS

All individuals aged 18 years and older with more than 6 months of cannabis use at the time of surgical repair for cardiovascular disease (aortic aneurysms or aortic dissection) between 2007 and 2023 were eligible. Patients were stratified into 2 groups based on their preoperative history of cannabis use: cannabis users and noncannabis users. The primary end point was complications or death within 30 days of intervention. Secondary outcomes included late complications and reinterventions. Data were combined from our institution and inpatient hospital records.

RESULTS

We identified 134 patients who met the inclusion criteria out of 1543 treated patients (9%). Compared with the nonusing cannabis group, individuals in the cannabis group were significantly younger (cannabis: 48.3 ± 11.8 years vs noncannabis: 58.5 ± 14.9 years;  < .001). The cannabis group included significantly higher patients with Marfan syndrome (cannabis: 11.2% vs noncannabis: 4.4%;  < .001). Furthermore, the cannabis group showed significantly higher history of recreational drug use, including cocaine (25.4% vs 1.6%;  < .001), amphetamines (3.7% vs 0.6%;  < .001), opioids (8.2% vs 0.5%;  < .001), and intravenous drugs (6.7% vs 0.6%;  < .001). Emergency surgeries were significantly more frequent in the cannabis group (cannabis: 56.7% vs noncannabis: 36.2%;  < .001). Surgical mortality was comparable between both groups (cannabis: 9.7% vs noncannabis: 8.6%;  = .662). Postoperative stroke was significantly higher in the cannabis group (cannabis: 14.9% vs noncannabis: 8.2%;  = .009), and the rate of postoperative respiratory complications was also significantly higher in the cannabis group (cannabis: 32.1% vs noncannabis: 19.0%;  < .001).

CONCLUSIONS

The increased rates of postoperative cerebrovascular accidents and respiratory complications suggest that cannabis use is a significant risk factor in aortic surgery. Our study showed that young, healthy patients with prolonged cannabis use might be at a higher risk of requiring more emergency surgeries due to their background.

摘要

目的

探讨大麻消费对主动脉瘤或主动脉夹层患者中长期手术结局的影响。

方法

所有年龄在18岁及以上、在2007年至2023年期间因心血管疾病(主动脉瘤或主动脉夹层)接受手术修复时使用大麻超过6个月的个体均符合条件。根据患者术前大麻使用史将其分为两组:大麻使用者和非大麻使用者。主要终点是干预后30天内的并发症或死亡。次要结局包括晚期并发症和再次干预。数据来自我们机构和住院医院记录。

结果

在1543例接受治疗的患者中,我们确定了134例符合纳入标准的患者(9%)。与非大麻使用组相比,大麻组个体明显更年轻(大麻组:48.3±11.8岁,非大麻组:58.5±14.9岁;P<0.001)。大麻组中患有马凡综合征的患者明显更多(大麻组:11.2%,非大麻组:4.4%;P<0.001)。此外,大麻组有娱乐性药物使用史的比例明显更高,包括可卡因(25.4%对1.6%;P<0.001)、苯丙胺(3.7%对0.6%;P<0.001)、阿片类药物(8.2%对0.5%;P<0.001)和静脉注射药物(6.7%对0.6%;P<0.001)。大麻组急诊手术明显更频繁(大麻组:56.7%,非大麻组:36.2%;P<0.001)。两组手术死亡率相当(大麻组:9.7%,非大麻组:8.6%;P=0.662)。大麻组术后中风发生率明显更高(大麻组:14.9%,非大麻组:8.2%;P=0.009),大麻组术后呼吸并发症发生率也明显更高(大麻组:32.1%,非大麻组:19.0%;P<0.001)。

结论

术后脑血管意外和呼吸并发症发生率增加表明,大麻使用是主动脉手术中的一个重要危险因素。我们的研究表明,长期使用大麻的年轻健康患者由于其背景可能更有可能需要更多的急诊手术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1399/11704534/9cca42e87201/fx1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验